Chronic renal failure caused by hypertension or by parenchymal kidney
disease is a very common global health problem. Patients with chronic
renal failure have two therapeutic options, dialysis and transplantati
on, of which transplantation has become a preferred modality. This rev
iew article is an update of a more comprehensive previous review (Semi
n Nucl Med, 181-198, 1988) and concentrates on the changes that have t
aken place in this field in recent years. These changes comprise new c
riteria for the selection of transplant candidates, newer techniques f
or the diagnosis of medical and surgical complications after transplan
tation, the use of new tracers (Tc-99m MAG3), and new antirejection re
gimens. Copyright (C) 1995 by W.B. Saunders Company